Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:17 PM
Ignite Modification Date:
2025-12-24 @ 12:17 PM
NCT ID:
NCT01939561
Eligibility Criteria:
Inclusion Criteria:
* Clinical myotonia: Myotonia affecting patients daily life, such as chewing function, handshake, initiation of walking and running, or dropping objects. Patients in antimyotonic treatment.
* Gen-verified diagnosis: Myotonia Congenita, Paramyotonia Congenita, Potassium-aggravated Myotonia or Dystrophia Myotonica type 1.
Exclusion Criteria:
* In treatment with medicines affecting the study results, estimated by investigators.
* Participated in other drug-trials within 30 days prior to study start.
* Known intolerance or allergy to Lamotrigine.
* Significant renal or liver function, epilepsy, or long QT interval on the ECG.
* Pregnancy and breast-feeding.
* After the investigators discretion
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT01939561
Study Brief:
Protocol Section:
NCT01939561